ZA200903499B - Indoles which act as via receptor antagonists - Google Patents
Indoles which act as via receptor antagonistsInfo
- Publication number
- ZA200903499B ZA200903499B ZA200903499A ZA200903499A ZA200903499B ZA 200903499 B ZA200903499 B ZA 200903499B ZA 200903499 A ZA200903499 A ZA 200903499A ZA 200903499 A ZA200903499 A ZA 200903499A ZA 200903499 B ZA200903499 B ZA 200903499B
- Authority
- ZA
- South Africa
- Prior art keywords
- indoles
- act
- receptor antagonists
- via receptor
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06125663 | 2006-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200903499B true ZA200903499B (en) | 2010-03-31 |
Family
ID=38983746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200903499A ZA200903499B (en) | 2006-12-08 | 2009-05-20 | Indoles which act as via receptor antagonists |
Country Status (21)
Country | Link |
---|---|
US (4) | US20080139618A1 (ko) |
EP (1) | EP2089381B1 (ko) |
JP (1) | JP2010511660A (ko) |
KR (1) | KR101050558B1 (ko) |
CN (1) | CN101541786A (ko) |
AR (1) | AR064137A1 (ko) |
AT (1) | ATE472544T1 (ko) |
AU (1) | AU2007328994B2 (ko) |
BR (1) | BRPI0720441A2 (ko) |
CA (1) | CA2671324A1 (ko) |
CL (1) | CL2007003503A1 (ko) |
DE (1) | DE602007007512D1 (ko) |
ES (1) | ES2345132T3 (ko) |
IL (1) | IL198683A0 (ko) |
MX (1) | MX2009005541A (ko) |
NO (1) | NO20091832L (ko) |
PE (1) | PE20081380A1 (ko) |
RU (1) | RU2009120443A (ko) |
TW (1) | TW200829570A (ko) |
WO (1) | WO2008068184A1 (ko) |
ZA (1) | ZA200903499B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE527249T1 (de) * | 2006-12-08 | 2011-10-15 | Hoffmann La Roche | Indole |
ATE472544T1 (de) * | 2006-12-08 | 2010-07-15 | Hoffmann La Roche | Als via-rezeptor-antagonisten verwendbare indole |
PE20081401A1 (es) * | 2006-12-28 | 2008-10-24 | Hoffmann La Roche | Derivados de indol como antagonistas de receptores vasopresina |
US20100145805A1 (en) * | 2008-12-08 | 2010-06-10 | Electronics And Telecommunications Research Institute | Apparatus for providing digital contents using dmb channel and method thereof |
EP2956441A4 (en) * | 2013-02-18 | 2016-11-02 | Scripps Research Inst | MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL |
GB201521059D0 (en) | 2015-11-30 | 2016-01-13 | Isis Innovation | Inhibitors of metallo-beta-lactamases |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5924990B2 (ja) * | 1979-11-21 | 1984-06-13 | 協和醗酵工業株式会社 | 新規なピペリジン誘導体 |
TW199153B (ko) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
CA2166975C (en) * | 1993-07-16 | 2005-04-05 | Mark G. Bock | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
CO5150201A1 (es) | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
DK1283838T3 (da) | 2000-05-12 | 2004-03-22 | Solvay Pharm Bv | Piperazin- og piperidinforbindelser |
AU2003301436A1 (en) | 2002-10-17 | 2004-05-04 | Amgen Inc. | Benzimidazole derivatives and their use as vanilloid receptor ligands |
DE602006004997D1 (de) | 2005-07-14 | 2009-03-12 | Hoffmann La Roche | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors |
ATE414078T1 (de) * | 2005-07-21 | 2008-11-15 | Hoffmann La Roche | Indol-3-ylcarbonylpiperidinbenzimidazolderivate als v1a-rezeptorantagonisten |
EP1931680B1 (en) | 2005-09-28 | 2010-11-17 | F. Hoffmann-La Roche AG | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
ATE472544T1 (de) * | 2006-12-08 | 2010-07-15 | Hoffmann La Roche | Als via-rezeptor-antagonisten verwendbare indole |
-
2007
- 2007-11-29 AT AT07847501T patent/ATE472544T1/de active
- 2007-11-29 AU AU2007328994A patent/AU2007328994B2/en not_active Ceased
- 2007-11-29 US US11/947,195 patent/US20080139618A1/en not_active Abandoned
- 2007-11-29 MX MX2009005541A patent/MX2009005541A/es active IP Right Grant
- 2007-11-29 EP EP07847501A patent/EP2089381B1/en not_active Not-in-force
- 2007-11-29 CN CNA2007800421348A patent/CN101541786A/zh active Pending
- 2007-11-29 DE DE602007007512T patent/DE602007007512D1/de active Active
- 2007-11-29 US US11/947,266 patent/US20080139617A1/en not_active Abandoned
- 2007-11-29 KR KR1020097011629A patent/KR101050558B1/ko not_active IP Right Cessation
- 2007-11-29 ES ES07847501T patent/ES2345132T3/es active Active
- 2007-11-29 US US11/947,146 patent/US8071622B2/en not_active Expired - Fee Related
- 2007-11-29 RU RU2009120443/04A patent/RU2009120443A/ru not_active Application Discontinuation
- 2007-11-29 US US11/998,371 patent/US7799923B2/en not_active Expired - Fee Related
- 2007-11-29 BR BRPI0720441-8A patent/BRPI0720441A2/pt not_active IP Right Cessation
- 2007-11-29 WO PCT/EP2007/062984 patent/WO2008068184A1/en active Application Filing
- 2007-11-29 JP JP2009539706A patent/JP2010511660A/ja active Pending
- 2007-11-29 CA CA002671324A patent/CA2671324A1/en not_active Abandoned
- 2007-12-05 CL CL200703503A patent/CL2007003503A1/es unknown
- 2007-12-05 AR ARP070105428A patent/AR064137A1/es unknown
- 2007-12-06 TW TW096146544A patent/TW200829570A/zh unknown
- 2007-12-07 PE PE2007001745A patent/PE20081380A1/es not_active Application Discontinuation
-
2009
- 2009-05-11 NO NO20091832A patent/NO20091832L/no not_active Application Discontinuation
- 2009-05-11 IL IL198683A patent/IL198683A0/en unknown
- 2009-05-20 ZA ZA200903499A patent/ZA200903499B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US7799923B2 (en) | 2010-09-21 |
NO20091832L (no) | 2009-07-07 |
WO2008068184A1 (en) | 2008-06-12 |
DE602007007512D1 (de) | 2010-08-12 |
AR064137A1 (es) | 2009-03-18 |
PE20081380A1 (es) | 2008-09-18 |
AU2007328994B2 (en) | 2012-03-08 |
KR101050558B1 (ko) | 2011-07-19 |
ATE472544T1 (de) | 2010-07-15 |
KR20090078368A (ko) | 2009-07-17 |
JP2010511660A (ja) | 2010-04-15 |
BRPI0720441A2 (pt) | 2014-01-07 |
CN101541786A (zh) | 2009-09-23 |
US20080269290A1 (en) | 2008-10-30 |
US8071622B2 (en) | 2011-12-06 |
US20080139617A1 (en) | 2008-06-12 |
CL2007003503A1 (es) | 2008-07-04 |
CA2671324A1 (en) | 2008-06-12 |
TW200829570A (en) | 2008-07-16 |
EP2089381B1 (en) | 2010-06-30 |
MX2009005541A (es) | 2009-06-05 |
US20080139548A1 (en) | 2008-06-12 |
IL198683A0 (en) | 2010-02-17 |
EP2089381A1 (en) | 2009-08-19 |
RU2009120443A (ru) | 2011-01-20 |
US20080139618A1 (en) | 2008-06-12 |
ES2345132T3 (es) | 2010-09-15 |
AU2007328994A1 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20151108T1 (en) | Nogo receptor antagonists | |
ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
EP2058304A4 (en) | P2X4 RECEPTOR ANTAGONIST | |
EP2244575A4 (en) | ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR | |
SI2094690T1 (sl) | Derivati 2-aza-biciklo(3.1.0)heksana kot antagonisti receptorja za oreksin | |
EP2151236A4 (en) | G PROTEIN COUPLED RECEPTOR AGONIST | |
IL187424A0 (en) | C5a RECEPTOR ANTAGONISTS | |
HK1136302A1 (en) | Progesterone receptor antagonists | |
EP2184278A4 (en) | P2X4 RECEIVER ANTAGONIST | |
EP2009992A4 (en) | ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR | |
IL196587A0 (en) | 2-phenyl-indoles as prostaglandin d2 receptor antagonists | |
ZA200705237B (en) | C5A receptor antagonists | |
EP1874302A4 (en) | ANTAGONISTS OF ANGIOTENSIN II RECEPTORS | |
IL198542A0 (en) | 2-aminoquinolines as 5-ht(5a)receptor antagonists | |
ZA200806065B (en) | Oxazoloisoquinoline derivatives as thrombin receptor antagonists | |
IL192693A0 (en) | Urotensin ii receptor antagonists | |
EP2153736A4 (en) | NEW LEUKOTRIEN RECEPTOR ANTAGONIST | |
ZA200903499B (en) | Indoles which act as via receptor antagonists | |
HK1137353A1 (en) | Urotensin ii receptor antagonists ii | |
ZA200904479B (en) | Nitroderivatives as angiotensin II receptor antagonists | |
IL202454A0 (en) | Urotensin ii receptor antagonists | |
ZA200802339B (en) | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists | |
ZA200903496B (en) | Spiro-piperidine derivatives as via receptor antagonists | |
EP2250168A4 (en) | ANTAGONISTS OF ANGIOTENSIN II RECEPTORS |